Cargando…

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

Development of B-cell-based hepatitis C virus (HCV) vaccines that induce broadly neutralizing antibodies (bNAbs) is hindered by extensive sequence diversity and low immunogenicity of envelope glycoprotein vaccine candidates, most notably soluble E2 (sE2). To overcome this, we employed two-component...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prentoe, Jannick, Janitzek, Christoph M., Velázquez-Moctezuma, Rodrigo, Soerensen, Andreas, Jørgensen, Thomas, Clemmensen, Stine, Soroka, Vladislav, Thrane, Susan, Theander, Thor, Nielsen, Morten A., Salanti, Ali, Bukh, Jens, Sander, Adam F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665036/ https://www.ncbi.nlm.nih.gov/pubmed/36379958 http://dx.doi.org/10.1038/s41541-022-00570-1

Ejemplares similares

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
por: Prentoe, Jannick, et al.
Publicado: (2021)

Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
por: Prentoe, Jannick, et al.
Publicado: (2018)

Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A
por: Velázquez-Moctezuma, Rodrigo, et al.
Publicado: (2017)

A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
por: Thrane, Susan, et al.
Publicado: (2015)

Virus-like particle display of HER2 induces potent anti-cancer responses
por: Palladini, Arianna, et al.
Publicado: (2018)

Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
por: Augestad, Elias H., et al.
Publicado: (2020)

Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency
por: Czarnota, Anna, et al.
Publicado: (2020)

Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses
por: Janitzek, Christoph M., et al.
Publicado: (2016)

Bacterial superglue enables easy development of efficient virus-like particle based vaccines
por: Thrane, Susan, et al.
Publicado: (2016)

In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus
por: Olesen, Christina Holmboe, et al.
Publicado: (2021)

HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
por: Prentoe, Jannick, et al.
Publicado: (2016)

Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies
por: Velázquez-Moctezuma, Rodrigo, et al.
Publicado: (2021)

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization
por: Pham, Long V., et al.
Publicado: (2022)

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
por: Janitzek, Christoph M., et al.
Publicado: (2019)

Analysis of Functional Differences between Hepatitis C Virus NS5A of Genotypes 1–7 in Infectious Cell Culture Systems
por: Scheel, Troels K. H., et al.
Publicado: (2012)

High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals
por: Pihl, Anne F., et al.
Publicado: (2018)

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
por: Aves, Kara-Lee, et al.
Publicado: (2022)

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
por: Thrane, Susan, et al.
Publicado: (2020)

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration
por: Janitzek, Christoph M., et al.
Publicado: (2021)

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design
por: Keck, Zhen-Yong, et al.
Publicado: (2019)

Genetic and structural insights into broad neutralization of hepatitis C virus by human V(H)1-69 antibodies
por: Tzarum, Netanel, et al.
Publicado: (2019)

Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies
por: Harmsen, Charlotte, et al.
Publicado: (2020)

Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems
por: Fredsgaard, Laurits, et al.
Publicado: (2021)

Identification of novel neutralizing determinants for protection against HCV
por: Alzua, Garazi P., et al.
Publicado: (2023)

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
por: Fougeroux, Cyrielle, et al.
Publicado: (2021)

An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
por: Tzarum, Netanel, et al.
Publicado: (2020)

Evidence of RedOX Imbalance during Zika Virus Infection Promoting the Formation of Disulfide-Bond-Dependent Oligomers of the Envelope Protein
por: Lebeau, Grégorie, et al.
Publicado: (2022)

Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser
por: Tsen, Shaw-Wei D, et al.
Publicado: (2014)

Survival of Enveloped and Non-Enveloped Viruses on Inanimate Surfaces
por: Firquet, Swan, et al.
Publicado: (2015)

Enveloped and non-enveloped virus survival on microfiber towels
por: Anderson, Claire E., et al.
Publicado: (2023)

Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model
por: Luo, Dan, et al.
Publicado: (2020)

Fusion of Enveloped Viruses in Endosomes
por: White, Judith M., et al.
Publicado: (2016)

Assembly of Viruses: Enveloped Particles
por: Navaratnarajah, C.K., et al.
Publicado: (2008)

Cell Entry of Enveloped Viruses
por: Cosset, François-Loic, et al.
Publicado: (2011)

Membrane Glycoproteins of Enveloped Viruses
por: Compans, Richard W., et al.
Publicado: (1978)

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
por: Smit, Merel J, et al.
Publicado: (2023)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions
por: Lavstsen, Thomas, et al.
Publicado: (2003)

A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses
por: Farzani, Touraj Aligholipour, et al.
Publicado: (2020)

Virus envelope acquisition of nuclear polyhedrosis virus in vitro.
por: Shang-Yin, G.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_gi5gb068g54jo2152n372n4mmu